BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36152515)

  • 1. Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy.
    Jiang H; Fu H; Guo Y; Hu P; Shi J
    Biomaterials; 2022 Oct; 289():121799. PubMed ID: 36152515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded
    Wei B; Pan J; Yuan R; Shao B; Wang Y; Guo X; Zhou S
    Nano Lett; 2021 May; 21(10):4231-4240. PubMed ID: 33998789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure.
    Chen C; Ni X; Jia S; Liang Y; Wu X; Kong D; Ding D
    Adv Mater; 2019 Dec; 31(52):e1904914. PubMed ID: 31696981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform.
    Wang Y; Xu H; Wang D; Lu Y; Zhang Y; Cheng J; Xu X; Chen X; Li J
    Acta Biomater; 2024 Jan; 174():358-371. PubMed ID: 38092253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Stress Amplifiers as Immunogenic Cell Death Nanoinducers Disrupting Mitochondrial Redox Homeostasis for Cancer Immunotherapy.
    Wan J; Zhang X; Li Z; Mo F; Tang D; Xiao H; Wang J; Rong G; Liu T
    Adv Healthc Mater; 2023 Apr; 12(9):e2202710. PubMed ID: 36527737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting immunogenic cell death in cancer.
    Ahmed A; Tait SWG
    Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy.
    Huang C; Lin B; Chen C; Wang H; Lin X; Liu J; Ren Q; Tao J; Zhao P; Xu Y
    Adv Mater; 2022 Dec; 34(51):e2207593. PubMed ID: 36245299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer.
    Zhang W; Chen G; Chen Z; Yang X; Zhang B; Wang S; Li Z; Yang Y; Wu Y; Liu Z; Yu Z
    J Control Release; 2024 Jun; 371():470-483. PubMed ID: 38849094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy.
    Li C; Wang L; Li Z; Li Z; Zhang K; Cao L; Wang Z; Shen C; Chen L
    Int J Pharm; 2024 Feb; 651():123729. PubMed ID: 38142016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-mediated immunogenic cell death for cancer immunotherapy.
    Qi H; Li Y; Geng Y; Wan X; Cai X
    Int J Pharm; 2024 May; 656():124045. PubMed ID: 38561134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-heating mitochondrion-induced free radical blast for immunogenic cell death stimulation and HCC immunotherapy.
    Peng M; Dong H; Shao M; Zhang X; Sun J; Ding C; Han X; Yang Q; Sang X; Cao G
    J Control Release; 2024 Feb; 366():694-711. PubMed ID: 38228273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential receptor-mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment.
    Shen J; Sun C; Wang Z; Chu Z; Liu C; Xu X; Xia M; Zhao M; Wang C
    Int J Pharm; 2021 May; 601():120553. PubMed ID: 33794325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
    Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
    J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cascade-Targeted Enzyme-Instructed Peptide Self-Assembly Strategy for Cancer Immunotherapy through Boosting Immunogenic Cell Death.
    Xie L; Ding Y; Zhang X; Zhang Z; Zeng S; Wang L; Yang Z; Liu Q; Hu ZW
    Small Methods; 2023 May; 7(5):e2201416. PubMed ID: 36965100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mitochondria-targeted anticancer copper dithiocarbamate amplifies immunogenic cuproptosis and macrophage polarization.
    Lu Y; Fan X; Pan Q; He B; Pu Y
    J Mater Chem B; 2024 Feb; 12(8):2006-2014. PubMed ID: 38291990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus guidelines for the detection of immunogenic cell death.
    Kepp O; Senovilla L; Vitale I; Vacchelli E; Adjemian S; Agostinis P; Apetoh L; Aranda F; Barnaba V; Bloy N; Bracci L; Breckpot K; Brough D; Buqué A; Castro MG; Cirone M; Colombo MI; Cremer I; Demaria S; Dini L; Eliopoulos AG; Faggioni A; Formenti SC; Fučíková J; Gabriele L; Gaipl US; Galon J; Garg A; Ghiringhelli F; Giese NA; Guo ZS; Hemminki A; Herrmann M; Hodge JW; Holdenrieder S; Honeychurch J; Hu HM; Huang X; Illidge TM; Kono K; Korbelik M; Krysko DV; Loi S; Lowenstein PR; Lugli E; Ma Y; Madeo F; Manfredi AA; Martins I; Mavilio D; Menger L; Merendino N; Michaud M; Mignot G; Mossman KL; Multhoff G; Oehler R; Palombo F; Panaretakis T; Pol J; Proietti E; Ricci JE; Riganti C; Rovere-Querini P; Rubartelli A; Sistigu A; Smyth MJ; Sonnemann J; Spisek R; Stagg J; Sukkurwala AQ; Tartour E; Thorburn A; Thorne SH; Vandenabeele P; Velotti F; Workenhe ST; Yang H; Zong WX; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2014 Oct; 3(9):e955691. PubMed ID: 25941621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypeptide-Based K
    Lee D; Ha J; Ahn H; Jeong SD; Jeong M; Park JH; Yun CO; Kim YC
    ACS Appl Bio Mater; 2021 Dec; 4(12):8333-8342. PubMed ID: 35005917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomaterials That Induce Immunogenic Cell Death.
    Li D; Liu S; Ma Y; Liu S; Liu Y; Ding J
    Small Methods; 2023 May; 7(5):e2300204. PubMed ID: 37116170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocatalytic bacteria disintegration reverses immunosuppression of colorectal cancer.
    Jiang H; Guo Y; Yu Z; Hu P; Shi J
    Natl Sci Rev; 2022 Nov; 9(11):nwac169. PubMed ID: 36381212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbes mediated immunogenic cell death in cancer immunotherapy.
    Huang J; Duan F; Xie C; Xu J; Zhang Y; Wang Y; Tang YP; Leung EL
    Immunol Rev; 2024 Jan; 321(1):128-142. PubMed ID: 37553793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.